摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-methylthiophen-2-yl)pyridine | 837376-35-9

中文名称
——
中文别名
——
英文名称
3-(3-methylthiophen-2-yl)pyridine
英文别名
——
3-(3-methylthiophen-2-yl)pyridine化学式
CAS
837376-35-9
化学式
C10H9NS
mdl
——
分子量
175.254
InChiKey
JIOQSJVEVFADJG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    270.9±25.0 °C(Predicted)
  • 密度:
    1.140±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    41.1
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:5af1a7367bd5f6a2f0eb31bbda2ea0f0
查看

反应信息

  • 作为产物:
    描述:
    2-溴-3-甲基噻吩3-吡啶硼酸四(三苯基膦)钯 、 sodium carbonate 作用下, 以 乙二醇二甲醚 为溶剂, 反应 1.0h, 以87%的产率得到3-(3-methylthiophen-2-yl)pyridine
    参考文献:
    名称:
    5-Substituted, 6-Substituted, and Unsubstituted 3-Heteroaromatic Pyridine Analogues of Nicotine as Selective Inhibitors of Cytochrome P-450 2A6
    摘要:
    A series of 5- and 6-substituted and unsubstituted 3-heteroaromatic analogues of nicotine were synthesized in an effort to delineate the structural requirements for selectively inhibiting human cytochrome P-450 (CYP) 2A6, the major nicotine metabolizing enzyme. Thiophene, substituted thiophene, furan, substituted furan, imidazole, substituted imidazole, pyridine, substituted pyridine, thiazole, and quinoline moieties were used to replace the N-methylpyrrolidine ring of nicotine. Bromo and methyl groups were introduced at the 5-position of the pyridine ring and fluoro, chloro, and methoxy groups were placed at the 6-position of the pyridine ring in order to explore the structure-activity relationship (SAR) of inhibition of CYP2A6. The inhibitory activity of the most potent CYP2A6 inhibitors on the functional activity of human cytochrome P450s 3A4, 2E1, 2136, 2C9, 2C19, and 2D6 was also examined to determine inhibitor selectivity. We identified 36 compounds that were more potent than nicotine at inhibition of coumarin 7-hydroxylase (CYP2A6) activity. We also found a number of compounds to be highly selective for the inhibition of human CYP2A6 versus the other human CYPs examined.
    DOI:
    10.1021/jm049696n
点击查看最新优质反应信息

文献信息

  • Palladium-Catalysed C2 or C5 Direct Arylation of 3-Substituted Thiophenes with Aryl Bromides
    作者:Henri Doucet、Jia Dong、David Roy、Reny Roy、Marina Ionita
    DOI:10.1055/s-0030-1260213
    日期:2011.11
    catalyst for the direct arylation of 3-substituted thiophene derivatives. The regioselectivity of the arylation strongly depends on the thiophene substituent and also on the nature of the aryl bromide. When using 3-formyl, 3-cyano, 3-methyl, 3-hydroxymethyl or 3-bromothiophene, the 2-arylated thiophenes were obtained with 76-95% regioselectivity; whereas, the arylation of 3-formylthiophene diethylacetal
    钯(OAc)2发现/ dppb体系是3-取代的噻吩衍生物直接芳基化的有效催化剂。芳基化的区域选择性在很大程度上取决于噻吩取代基以及芳基溴化物的性质。当使用3-甲酰基,3-氰基,3-甲基,3-羟甲基或3-溴噻吩时,以76-95%的区域选择性得到2-芳基化的噻吩。而3-甲酰基噻吩二乙基缩醛或3-乙酰基噻吩的芳基化得到5-芳基噻吩的区域选择性为52-90%。拥挤的芳基溴化物的使用有利于C5处的芳基化。这些反应仅使用0.1mol%的催化剂进行。此外,已经发现该方法耐受芳基溴化物上的各种官能团,例如甲酰基,丙酰基,苯甲酰基,腈和硝基。 催化-钯-噻吩-芳基化-CH键活化
  • [EN] SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER<br/>[FR] COMPOSES SYNTHETIQUES ET DERIVES DE CEUX-CI EN TANT QUE MODULATEURS DE FUMEE OU D'INGESTION DE NICOTINE ET DU CANCER DU POUMON
    申请人:HUMAN BIOMOLECULAR RES INST
    公开号:WO2005066162A1
    公开(公告)日:2005-07-21
    Disclosed are nicotine-related compounds that selectively inhibit cytochrome P-450 2A6 (CYP2A6), selectively inhibit cytochrome P-450 2A13 (CYP2A13), and/or selectively modulate a nicotinic acetylcholine receptor (nAChR). Also disclosed are pharmaceutical compositions comprising a compound of the invention, as well as methods of using the pharmaceutical compositions for treating or preventing a disease or disorder associated with nicotine-ingestion, or a disease or disorder amenable to treatment by selective modulation of nAChRs.
    本公开了与尼古丁相关的化合物,其选择性地抑制细胞色素P-450 2A6(CYP2A6),选择性地抑制细胞色素P-450 2A13(CYP2A13),和/或选择性地调节尼古丁型乙酰胆碱受体(nAChR)。还公开了包含本发明化合物的药物组合物,以及使用这些药物组合物治疗或预防与尼古丁摄入相关的疾病或紊乱,或者通过选择性调节nAChRs治疗的疾病或紊乱的方法。
  • Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer
    申请人:Cashman John R.
    公开号:US20080188527A1
    公开(公告)日:2008-08-07
    Disclosed are nicotine-related compounds that selectively inhibit cytochrome P-450 2A6 (CYP2A6), selectively inhibit cytochrome P-450 2A13 (CYP2A13), and/or selectively modulate a nicotinic acetylcholine receptor (nAChR). Also disclosed are pharmaceutical compositions comprising a compound of the invention, as well as methods of using the pharmaceutical compositions for treating or preventing a disease or disorder associated with nicotine-ingestion, or a disease or disorder amenable to treatment by selective modulation of nAChRs.
    本发明涉及选择性抑制细胞色素P-450 2A6(CYP2A6)、选择性抑制细胞色素P-450 2A13(CYP2A13)和/或选择性调节尼古丁乙酰胆碱受体(nAChR)的尼古丁相关化合物。本发明还涉及包含本发明化合物的制药组合物,以及使用该制药组合物治疗或预防与尼古丁摄入相关的疾病或障碍,或可通过选择性调节nAChR进行治疗的疾病或障碍的方法。
  • SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER
    申请人:Cashman John R.
    公开号:US20100298345A1
    公开(公告)日:2010-11-25
    Disclosed are nicotine-related compounds that selectively inhibit cytochrome P-450 2A6 (CYP2A6), selectively inhibit cytochrome P-450 2A13 (CYP2A13), and/or selectively modulate a nicotinic acetylcholine receptor (nAChR). Also disclosed are pharmaceutical compositions comprising a compound of the invention, as well as methods of using the pharmaceutical compositions for treating or preventing a disease or disorder associated with nicotine-ingestion, or a disease or disorder amenable to treatment by selective modulation of nAChRs.
    本发明涉及选择性抑制细胞色素P-450 2A6(CYP2A6)的尼古丁相关化合物,选择性抑制细胞色素P-450 2A13(CYP2A13),和/或选择性调节尼古丁乙酰胆碱受体(nAChR)。本发明还涉及包含本发明化合物的制药组合物,以及使用该制药组合物治疗或预防与尼古丁摄入有关的疾病或障碍,或者通过选择性调节nAChRs进行治疗的疾病或障碍的方法。
  • PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFICATION PRODUCT THEREOF
    申请人:Fujifilm Corporation
    公开号:EP3168848A1
    公开(公告)日:2017-05-17
    A photoelectric conversion element which comprises a conductive support, a photosensitive layer containing an electrolyte, a charge transfer layer containing an electrolyte and a counter electrode, and wherein the photosensitive layer comprises semiconductor fine particles that support a metal complex dye represented by a specific formula; a dye-sensitized solar cell; a metal complex dye; a dye solution; and a terpyridine compound or an esterification product thereof.
    一种光电转换元件,它包括导电支架、含有电解质的光敏层、含有电解质的电荷转移层和对电极,其中光敏层由半导体微粒组成,该半导体微粒支持以特定公式表示的金属络合染料;一种染料敏化太阳能电池;一种金属络合染料;一种染料溶液;以及一种萜吡啶化合物或其酯化产物。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-